What medication list should be used for an adult patient with pain, including analgesics, neuropathic agents, and supportive drugs, with appropriate dosing and considerations for renal impairment and older adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Comprehensive Pain Medication List for Adult Patients

For adult patients with pain, use a stepwise approach starting with acetaminophen as first-line, followed by neuropathic agents (gabapentinoids or antidepressants) for neuropathic components, with topical agents as adjuncts, while implementing slower titration and dose reductions in elderly patients and those with renal impairment.

First-Line Analgesics

Acetaminophen

  • Starting dose: 1,000 mg orally
  • Maximum: <4 g/24 hours from all sources 1
  • Rationale: Safest option with no significant GI bleeding, renal, or cardiovascular toxicity
  • Elderly consideration: Often effective at 1,000 mg before escalating to stronger medications

Neuropathic Pain Agents

Gabapentinoids (First-Line for Neuropathic Pain)

Pregabalin (preferred for easier titration) 2, 3:

  • Starting dose: 25-50 mg daily (elderly/renal impairment); 50 mg three times daily (standard)
  • Target dose: 100 mg three times daily
  • Maximum: 600 mg daily in divided doses
  • Titration: Slower in elderly or medically frail
  • Renal adjustment: Required - reduce dose or extend interval

Gabapentin 2, 3:

  • Starting dose: 100-200 mg nightly (elderly); 100-300 mg nightly (standard)
  • Target dose: 900-3,600 mg daily in 2-3 divided doses
  • Titration: Increase by 50-100% every few days; slower for elderly
  • Renal adjustment: Required - dose reduction needed 4

Antidepressants for Neuropathic Pain

Secondary Amines (Better Tolerated) 2:

Nortriptyline or Desipramine:

  • Starting dose: 10-25 mg nightly
  • Target dose: 50-150 mg nightly
  • Titration: Increase every 3-5 days until tolerated
  • Advantage: Fewer anticholinergic effects than tertiary amines

Tertiary Amines (More Efficacious but Less Tolerated):

Amitriptyline or Imipramine:

  • Starting dose: 10-25 mg nightly
  • Target dose: 50-150 mg nightly
  • Caution: Higher risk of sedation, dry mouth, urinary hesitancy - avoid in elderly when possible

SNRIs 2:

Duloxetine:

  • Starting dose: 30-60 mg daily
  • Target dose: 60-120 mg daily

Venlafaxine:

  • Starting dose: 50-75 mg daily
  • Target dose: 75-225 mg daily

Bupropion:

  • Starting dose: 100-150 mg daily
  • Target dose: 150-450 mg daily

Topical Agents (High Safety Profile)

Lidocaine 5% Patch 2, 3:

  • Apply daily to painful site
  • Minimal systemic absorption - excellent for elderly

Diclofenac Gel:

  • Apply three times daily to affected area

Diclofenac Patch:

  • 180 mg: one patch daily or twice daily

Muscle Relaxants (Use Cautiously)

Baclofen 1:

  • Starting dose: 5 mg up to three times daily
  • Maximum: Rarely tolerate >30-40 mg/day in elderly
  • Monitor: Muscle weakness, urinary function, cognitive effects, sedation
  • Caution: Avoid abrupt discontinuation

Tizanidine 1:

  • Starting dose: 2 mg up to three times daily
  • Monitor: Muscle weakness, urinary function, cognitive effects, sedation, orthostasis

Critical Dosing Considerations

Elderly Patients 2, 3, 5

  • Start low: Use lowest starting doses listed above
  • Go slow: Slower titration intervals to monitor effects
  • Monitor closely: Higher risk of cognitive impairment, falls, sedation
  • Effective doses: Often lower than standard ranges

Renal Impairment 2, 4, 6

Require Dose Adjustment:

  • Gabapentin: Reduce dose or extend interval
  • Pregabalin: Reduce dose or extend interval
  • Both gabapentinoids require adjustment at CrCl <60 mL/min

Avoid Entirely:

  • NSAIDs in chronic renal failure
  • Meperidine (pethidine)
  • Dextropropoxyphene

Safest Options in Renal Impairment:

  • Acetaminophen (avoid compound analgesics)
  • Fentanyl
  • Buprenorphine
  • Topical agents

Hepatic Impairment 6

  • Most drugs have impaired clearance and increased oral bioavailability
  • Use with caution and close monitoring
  • Avoid: Amitriptyline, carbamazepine, valproate (risk of fulminant hepatic failure)

Treatment Algorithm

  1. Assess pain type: Nociceptive vs. neuropathic vs. mixed
  2. Start acetaminophen: 1,000 mg for all pain types
  3. Add neuropathic agent if indicated:
    • Pregabalin (first choice for ease of titration) OR
    • Gabapentin (if pregabalin unavailable) OR
    • Nortriptyline/Desipramine (if gabapentinoids contraindicated)
  4. Add topical agent: Lidocaine patch or diclofenac for localized pain
  5. Titrate to effect: Until pain relief achieved, side effects unmanageable, or maximum dose reached 2
  6. Consider combination therapy: Opioid + antidepressant + anticonvulsant if monotherapy insufficient

Common Pitfalls to Avoid

  • Don't use in elderly: Amitriptyline (high anticholinergic burden), meperidine, pentazocine, dextropropoxyphene 7
  • Don't forget renal dosing: Both gabapentinoids require adjustment - failure to adjust causes toxicity
  • Don't rush titration: Elderly patients need slower increases to avoid falls, confusion, sedation
  • Don't ignore drug interactions: Screen for serotonin syndrome risk with multiple serotonergic agents 8
  • Don't use NSAIDs chronically: Especially in renal impairment or elderly (GI bleeding, cardiovascular risk)

Patient Education Points

  • Treatment is trial-and-error; don't get discouraged 2
  • Analgesic effect of antidepressants occurs earlier and at lower doses than antidepressant effect 2
  • Doses increase until effect achieved or side effects become unmanageable 2
  • Maximum safe acetaminophen dose is <4 g/24 hours from ALL sources (including OTC products) 1

References

Guideline

pharmacological management of persistent pain in older persons.

Journal of the American Geriatrics Society (JAGS), 2009

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Guideline

a practical approach to using adjuvant analgesics in older adults.

Journal of the American Geriatrics Society (JAGS), 2020

Guideline

consensus guidelines for oral dosing of primarily renally cleared medications in older adults.

Journal of the American Geriatrics Society (JAGS), 2009

Related Questions

What medication regimen should be used to manage a patient's inflammatory, neuropathic, and muscle‑spasm pain, accounting for contraindications to NSAIDs, renal or hepatic impairment, and providing options for breakthrough severe pain?
What is a concise pharmacologic pain management plan for a patient over 65 years old with chronic pain and creatinine clearance < 60 mL/min?
What non‑drying alternative therapies are appropriate for managing throat pain in an older adult?
What is the recommended analgesic regimen for elderly patients with mild to moderate pain, including dosing and safety considerations?
What is the appropriate medication regimen for chronic back pain in an elderly patient?
What is the appropriate evaluation and management of gross hematuria following trauma?
In a patient who is a chronic street fentanyl user, how long can fentanyl and its metabolite norfentanyl be detected in urine, and how should a low‑level positive result be interpreted and managed?
In a 27‑week pregnant woman presenting with lightheadedness, blurred vision, a feeling of fainting and shakiness that started after meals and when standing, with normal orthostatic vital signs, no chest pain, dyspnea, or headache, and a normal prenatal screen one week ago, what are the likely differential diagnoses and recommended management plan?
What medications are recommended for the treatment of COVID‑19 in outpatient and inpatient settings?
What are the typical inter-arm arterial pressure differences in unilateral significant subclavian artery stenosis?
Is hepatitis C virus genotyping required before prescribing Mavyret (glecaprevir/pibrentasvir)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.